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RESEARCH ARTICLE
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ABSTRACT
Objective: The aim with this study was to understand more about how general practitioners
(GPs) and nurses in primary care experience their work with medication reviews in elderly patients.
Design: This qualitative study was nested within a cluster randomised trial and analysed narra-
tive and unstructured diaries written by two pharmacists who performed academic detailing, i.e.
educational outreach visits in primary care. The educational sessions dealt with potentially
inappropriate medicines, and stimulated interprofessional dialogue in relation to medication
reviews. The purpose of the diaries was to document and structure the pedagogical process of
academic detailing and contained quotes from 194 GP and 113 nurse participants in the ses-
sions, and the pharmacists’ reflections. The data was explored using thematic analysis.
Setting: Thirty-three primary care practices in Stockholm, Sweden.
Subjects: GPs and nurses working in primary care.
Main outcome measures: Thematic descriptions of academic detailing by pharmacists.
Results: Five themes were identified: 1) Complexity in 3 ‘P’: patients, pharmacotherapy, and pri-
mary care; 2) What, when, who? Clash between GPs’ and nurses’ experiences and guidelines; 3)
Real-world problems and less-than-ideal solutions; 4) Eureka? Experiences with different steps
during a medication review; and 5) Threats to GP autonomy.
Conclusion: GPs and nurses should participate in the construction and release of guidelines in
order to increase their usability in clinical practice. Future research should analyse if alternative
strategies such as condensed medical reviews and feedback on prescribing are easier to imple-
ment in primary care.
KEY POINTS
 Complex medication reviews have been introduced on a large scale in Swedish primary care,
but knowledge on GPs’ and nurses’ views on such reviews is lacking.
 In the context of primary care alternative strategies such as condensed medication reviews
and feedback on prescribing may be more applicable than medication reviews according
to guidelines.
 GPs and nurses should make contributions to the development of guidelines on medication
reviews in order to increase their usability in clinical practice.
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Introduction
Elderly people often suffer from several diseases and
are treated with many drugs. As the number of drugs
increases, so does the subsequent risk for adverse
drug reactions [1]. Adverse drug effects may cause up
to 15% of unplanned hospitalizations in the elderly
population [2]. One possible measure to improve drug
treatment and make it more appropriate for the indi-
vidual patient is medication reviews (MRs) [3]. In many
cases MRs are performed by a team of pharmacist
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and physician. During a MR, the appropriateness of
drug treatment is assessed in relation to professional
experience or validated criteria of potentially inappro-
priate medicines (PIMs) such as Irish STOPP/START cri-
teria [4], Swedish ‘National indicators for quality of
drug therapy in elderly persons’ or Norwegian
NORGEP criteria [5]. Those criteria include for example
drug-drug interactions and ‘drugs to avoid’ such as
long acting benzodiazepines. However, the manner
in which MRs are performed differs between studies
or is not sufficiently described. This may partly be
due to the fact that it is unclear which aspects of a
MR are most important [6]. Moreover, the effects of
MRs are unclear [3]. Hospital-based MRs performed
in collaboration between physician and pharmacist
may reduce drug-related hospital admissions [7].
Effects of MRs performed in primary care have only
rarely been analysed systematically. Two studies per-
formed in Swedish primary care did not show a
reduction of drug-related problems or PIM use after
MRs [8] [9].
GPs have a central and connecting role in the
health care system. In Sweden, elderly people see
their GP on average four times a year. Still, Swedish
primary care does not have a gatekeeper function,
and patients may seek specialist care without refer-
ral. Patients may therefore fill prescriptions from
many different health care providers. At the same
time, there is no consensus among GPs regarding
their level of responsibility for the patients’ drug list
[10], which complicates the management of medical
care in elderly people. Other barriers to minimize
the use of PIMs are GPs feeling pressure from
patients to prescribe [11], lack of time and resources
[12], and a suboptimal communication between pri-
mary and secondary care [13]. GPs expressed help-
lessness in relation to polypharmacy in their elderly
patients and demand for simple measures to reduce
the use of PIMs [14].
In 2012, the Swedish National Board of Health and
Welfare revised the guidelines on ‘basic’ and ‘complex’
MRs in patients 75 years and older with at least five
drugs performed in primary and secondary care (sup-
plementary file) [15]. A financial incentive of 300 SEK
($35) was given by Stockholm County Council for
every basic MR performed in primary care and regis-
tered in the electronic patient record. Moreover, there
was a penalty for the practice if not at least 50% of
home care patients had been registered with a basic
MR. The aim with this study was to understand more
about general practitioners’ (GPs) and nurses’ views on
PIMs and MRs in elderly patients.
Material and methods
Study design and data collection
This was a qualitative study analysing narrative and
unstructured diaries written by two pharmacists (here-
after called tutors) who performed educational out-
reach visits in primary care. Diary writing is an
important data collection method in qualitative
research and may stimulate the creation of hypotheses
and help to identify problems [16]. A qualitative
approach was chosen because very little was known
about GPs’ and nurses’ experiences with MRs.
The educational outreach visits were part of a previ-
ous cluster randomised controlled trial [17]. We
designed this multifaceted educational intervention
based on the ‘National indicators for quality of drug
therapy in elderly persons’ [18] and the new guidelines
on MRs (supplementary file) [15]. The trial did neither
reduced the use of PIMs nor subsequent acute health
care consumption in elderly patients [17]. One aim of
the randomised trial had been to assist GPs and nurses
in developing a working procedure for complex MRs
according to the guidelines (supplementary file) [15].
The tutors worked for the regional drug and therapeu-
tics committee and had several years of experience
with academic detailing in primary care [19]. The writ-
ing of diaries was a standardised part of their working
procedures to document and structure the peda-
gogical process of academic detailing. Of note, the
tutors were not steered in their reporting and thus
had the maximum freedom of documenting whatever
they considered to be important regarding their pur-
pose (to document the pedagogical process). In the
context of our cluster randomised trial [17], they had
decided to do the same in all educational sessions.
When the tutors presented their diaries for the
research group, we discovered they contained unex-
pectedly rich and extensive data. As we were not
aware of any study dealing with GPs’ and nurses’
views on MRs according to guidelines, we decided to
analyse the diaries by a qualitative approach. The
tutors consented to the analysis of the diaries. As GPs
and nurses attending the educational sessions were
not aware the diaries would be analysed we applied
and obtained ethical approval to analyse them in add-
ition to the earlier approval for the cluster randomised
trial [17]. Moreover, GPs and nurses were anonymous
to the researchers, and it was not possible to identify
them based on the tutors’ diaries.
The educational sessions (1 - 2 hours) were directed
to both nurses and GPs and were given in Swedish.
Nurses have an important role in Swedish primary care
and in relation to patients’ drug treatment. District
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nurses prescribe drugs to a minor extent (less than 1%
of total prescriptions). Nurses regularly perform home
visits in elderly patients. However, they work under the
supervision of a GP [20]. District nurses often communi-
cate patients questions and complaints raised by the
patients to the GP and are suggested to actively moni-
tor side effect of drugs. The contents of the educational
sessions had been developed by two GPs, three phar-
macists and a nurse. During the sessions, it was referred
to the Swedish ‘National indicators for quality of drug
therapy in elderly persons’ [18], and the legislated two
types of MRs: basic and complex (supplementary file)
[15]. The following steps were part of the sessions: First,
the tutors gave a powerpoint-presentation on PIMs and
MRs according to the guidelines. Practice specific feed-
back was provided based on prescription data
extracted from the Central Regional Data Warehouse of
Stockholm County [21], which contains data on health
care consumption, drugs, migration, and deaths for all
2.1 million inhabitants of Stockholm County. For
example, we provided feedback on how many patients
aged 65 and older registered with the practice had
received long-acting benzodiazepines. Second, the
tutors asked GPs and nurses to create a working pro-
cedure on MRs by interprofessional dialogue. The tutors
were present during this dialogue and could support
the process. GPs and nurses shared each other’s
responses and thus gave additional comments, devel-
oped and completed their answers. The working pro-
cedure was documented on an A1-poster which was
set up in the practice as a reminder. Third, a second
educational session four months later was provided,
with repeated information on PIMs, written reminders
of the first session as well as relevant internet links in
relation to PIMs. Furthermore, GPs and nurses discussed
with the tutors if and how the working procedure on
MRs had been put into practice. Thus, the educational
sessions gave the tutors access to how GPs and nurses
were thinking about MRs and PIMs among elderly
patients in the context of primary care.
The tutors wrote in total 40 pages of diaries directly
after each educational session relying on their memo-
ries. No equipment was used to record the sessions.
The tutors visited 33 primary care practices on their
own twice within four months (Table 1). In total, 32/33
(97%) of the diaries on the first session, and 30/33
(91%) diaries on the second session were available,
and the diaries contained quotes from 194 GPs and
113 nurses participating in the educational sessions
(Table 1). The diaries contained three types of data.
First, the tutors directly quoted the specific GPs and
nurses who had participated in the sessions, for
example: ‘Who is responsible for what? I can’t stop a
medication initiated by another physician.’ Second, the
tutors made their own inferences regarding specific
GP or nurse comments, for example: “The physician
responsible for home care patients implied that a 90
year old patient does not benefit from treatment with
simvastatin.“ Third, the diaries reflected the tutors’ per-
sonal perceptions and experiences, for example:
‘though unspoken, there was a feeling that ‘we (the
GPs) are doing this all the time… we have always
done this’, at least in some people.’ Sometimes it was
not clear from the diaries if the healthcare professional
cited by the tutors was a GP or nurse.
Data analysis
A data driven inductive thematic analysis with no pre-
determined categories was performed in a stepwise
manner [19]. Thematic analysis permits to identify,
explore and report patterns within data in rich detail
[22], which is why we considered it to fit our aim but
even the character of our data material. As there is a
risk in qualitative research that preconceived notions
influence the way researchers interpret the data, the
analysing researchers KSM (GP) and PBR (behavioral
scientist) documented their preconceived notions
regarding PIMs and MRs prior to data assessment. This
is a way to reduce” reflexivity “(=”sensitivity to the
Table 1. Basic characteristics of the 33 primary care practices receiving the educational intervention
and where the tutors wrote diaries.
Variable 33 practices
Patients registered at practice
Median number of registered patients aged 65/practice (min-max) 1 529 (634-3394)
Median % of patients aged 65/all registered patients (min-max) 15.1 (7.4-24.2)
Employment
Median number of general practitioners/practice (min-max) 8.7 (2.2-18.3)
Median number of registered nurses/practice (min-max) 7.0 (2.0-12.0)
Participation in educational sessions
General practitioners: total number; median (min-max)
First session 194; 6 (min 1; max 17)
Second session 166; 5 (min 0; max 14)
Registered nurses: total number; median (min-max)
First session 113; 4 (min 0; max 7)
Second session 92; 3 (min 0; max 9)
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ways in which the researcher and the research process
have shaped the collected data“, quotation from [23])
and increase the quality of data analysis. Data was
anonymous with respect to practice, tutor and partici-
pants. During the first step of the analysis, we decided
which topic each sentence or paragraph was dealing
with. This topic was called a ‘code’, leading to a total
of 21 codes. Examples for such codes are: ‘frustration’,
or ‘responsibility for MR’. Next, diary quotes in each
coded group were evaluated looking for a possible
connection to diary quotes in another coded group.
This step of analysis led to the identification of five
independent themes. During the third and fourth step
of the analysis, KSM and PBR sifted through the diary
quotes, codes, themes and their potential relationship,
until consensus was reached. An iterative process was
used throughout the whole analysis, i.e. moving from
the diaries to the condensed description and back
again. Finally, a pattern of relationships between the
five themes was established.
When there was consensus among GPs and nurses
within a particular theme or subtheme, diary quotes
are presented in plain text boxes (example: box 1).
When GPs’ and nurses’ experiences differed from
guidelines (example: box 2) or when GPs’ and nurses’
experiences varied (example: box 3), we present diary
quotes in ‘variation thermometers’ illustrating the
extremes of experiences at the top and bottom of the
thermometer to the left side.
Box 1. Diary quotes being part of theme ‘Complexity in 3 ‘P’:
patients, pharmacotherapy, and primary care’.
1. Patients
 These patients have several challenges beyond the compli-
cated medical regimen
 With reference to screening for side effects with a standar-
dized questionnaire, one GP suggested that ‘all’ elderly
patients experience vertigo.
2. Pharmacotherapy
 The GP responsible for home care patients implied that a 90
year old patient does not benefit from treatment with simvas-
tatin. Another GP meant that withdrawing a drug treatment
based on a patient’s age was discriminatory against eld-
erly patients.
3. The role of primary care in the health care system
 Once I (tutor) had finished, a GP mentioned that medication
reviews are time-consuming, and that those providing differ-
ent educational sessions regard their particular topic as most
relevant. In addition, expectations with regard to primary
care continue to increase.
 Too difficult to get in contact with physicians working in
the hospital.
Ethical consideration
We obtained ethical approval for the qualitative ana-
lysis of the diaries (ethical board in Stockholm, DNR
2015/1927-32) in addition to earlier approval for the
cluster randomised trial [16] (ethical board in
Stockholm, DNR 2012/1266-31). The tutors’ diaries
served as the main source for the analysis. We
reported our research following the COREQ guidelines
which is a checklist containing 32 criteria for reporting
qualitative research [24].
Results
GPs’ and nurses’ views on MRs as proposed by the
guidelines and reported by the tutors could be
grouped into five themes. 1) Complexity in 3 ‘P’:
patients, pharmacotherapy, and primary care; 2) What,
when, who? Clash between GPs’ and nurses’ experien-
ces and guidelines; 3) Real-world problems and less-
than-ideal solutions; 4) Eureka? Experiences with differ-
ent steps during a medication review; and 5) Threats
to GP autonomy.
Theme 1: Complexity in 3 ‘P’: patients,
pharmacotherapy, and primary care
There was consensus among GPs and nurses regarding
the complexity of PIMs and MRs in elderly patients.
Complexity referred to three topics: patients, pharma-
cotherapy and primary care (box 1).
First, elderly patients often had complex problems
besides drug treatment. It was challenging to evaluate
their symptoms, as chronic disease and side effects
may cause the same symptoms making it difficult to
differentiate between them. Second, pharmacotherapy
was a complex subject. GPs often had to rely on their
clinical experience when deprescribing drugs in elderly
patients. There was consensus among GPs regarding
the complexity of elderly patients’ drug treatment but
they had different experiences on how to manage this
complexity. Third, primary care had a complex role in
the health care system and was responsible for mul-
tiple tasks, MRs in elderly patients being only one of
them. Moreover, communication between primary care
and healthcare professionals at hospitals
was suboptimal.
Theme 2: What, when, who? Clash between GPs’
and nurses’ experiences and the guidelines
GPs and nurses experiences with MRs differed in sev-
eral ways from the guidelines. Three subthemes
(=clashs), ‘what, when, who’ were identified (box 2).
First, in relation to ‘what is a MR’, there was a view
of consensus that the separation into ‘basic’ and
‘complex’ MRs was arbitrary and did not correspond to
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Box 2. Diary quotes (italic style) and quotes derived from the guidelines on medication reviews (normal style) being part
of theme ‘What, when, who? Clash between GPs and nurses experiences and the guidelines’. (Remark: When GPs and
nursesexperiences varied, diary quotes are presented as ‘variation thermometers’ illustrating the extremes of experiences
at the top and bottom of the thermometer to the left side).
1see supplementary file
GP: general practitioner
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE 333
the clinical experience of GPs and nurses actually
involved in the care of elderly patients. Second, in rela-
tion to ‘when should a MR be done’, they perceived
that MRs are a natural part of an everyday consult-
ation, and that MRs therefore were done continuously
and when needed. Third, the ‘who should receive a
MR’ referred to patients in need of MRs. GPs and
nurses doubted if patients in need of MRs should be
identified upon their age. Fourth, the ‘who is respon-
sible for a MR’ described that it is unclear if primary
care has the overall responsibility for the patient’s cur-
rent drug list, and to which extent a GP may change
prescriptions issued by other specialists.
Box 3. Diary quotes being part of theme ‘Real-world problems and less-than-ideal solutions’. (Remark: When GPs and
nursesexperiences varied, diary quotes are presented as ‘variation thermometers’ illustrating the extremes of experiences
at the top and bottom of the thermometer to the left side).
(continued)
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Theme 3: Real-world problems and less-than-
ideal solutions
In clinical practice, GPs and nurses may identify
numerous ‘real-world’ problems when trying to imple-
ment new guidelines. Sometimes they are forced to
find ‘less-than-ideal’ solutions because of unclear
guidelines or organizational obstacles. The real-world
problems and less-than-ideal solutions could be
grouped in four subthemes (box 3).
First, there was variation in experiences regarding
the practical solutions in relation to the initiation of
MRs, ‘patient vs. primary care’ and ‘GP vs. nurse’. Some
suggested that the practice should actively approach
patients in need of a MR, while others thought that
the patient should become active when interested in a
MR. Sometimes nurses initiated MRs, whereas in other
practices GPs initiated them. Second, there was vari-
ation regarding the GPs’ and nurses’ motivation to col-
laborate as well as their experiences regarding their
collaboration. Some considered the collaboration as
fruitful, whilst others experienced that the other part
(GP or nurse) did not want to collaborate. Third, there
was consensus regarding difficulties with the
documentation and the registration of MRs. The forms
to fill in during a MR were too complex, and it was
unclear how to code correctly for MRs in order to be
reimbursed. Furthermore, GPs and nurses agreed upon
obstacles related to the electronic medical record.
Important record notes were difficult to find, and syn-
chronization between different electronic systems was
suboptimal, both compromising patient safety. Fourth,
shortage of health care professionals was a hinder for
the conduct of MRs, as it was difficult to give the
patient an appointment with his registered GP and as
it was impossible to perform MRs in team of GP and
nurse as claimed by the guidelines.
Theme 4: Eureka? Experiences with different steps
during a MR
GPs’ and nurses’ experiences with different steps dur-
ing a MR as proposed by the guidelines were com-
piled in theme ‘Eureka? Experiences with MRs’ (box 4).
First, GPs’ and nurses’ experiences varied in relation
to the usefulness of standardized questionnaires
screening for side effects. Some experienced such
questionnaires to be useful tools, whereas others
GP: general practitionerweb application for prescriptions for drugs that are packed in individual dosage packetselectronic patient record used in Stockholm County
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thought that they caused more work and are difficult
to interpret. Some even meant that patients would
inform the GPs and nurses if they experienced side
effects. Second, there was consensus among GPs and
nurses regarding the value of calculating renal func-
tion. Third, GPs’ and nurses’ experiences regarding the
usefulness of MRs in general varied. Some experienced
that they were very useful, because they gave a more
holistic picture of the patient’s medical regimen, and
as many errors in the drug list were corrected. GPs
and nurses at one practice were not able to identify
any positive experiences with MRs and indicated that
the concept itself was completely unclear to them.
Theme 5: Threats to GPs’ autonomy
This theme illustrated how external steering and finan-
cial incentives counteract GPs’ autonomy and their
intention to offer the best medical care to their
patients (box 5). There was consensus among GPs
regarding both subthemes.
Box 4. Diary quotes being part of theme ‘Eureka? Experiences with different steps during a medication review’. (Remark:
When GPsand nursesexperiences varied, diary quotes are presented as ‘variation thermometers’ illustrating the extremes
of experiences at the top and bottom of the thermometer to the left side).
GP: general practitioner screening tool for safe medication use [41]
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Box 5. Diary quotes being part of theme ‘Threats to
GPs’ autonomy’.
1. External steering
 Now I (GP) will stop using my intuition and only fol-
low checklists.
 They (GPs and nurses) do not feel capable enough to estab-
lish a routine for medication review because the guidelines
they must follow are too strenuous. At the same time, they
do not want to cheat.
 Some of us are provoked by your presentation since we cur-
rently do and have done those things in the past, but others
understand that there are things we can learn and
improve upon.
2. Financial incentives
 In home care patients it is not always meaningful to do
reviews (for example the patients are recently discharged
from the hospital where a medication review was done), but
it must be repeated and coded again, otherwise we are
penalized. In those situations reviews, are a waste of time.
 The question remains—how can we possibly focus on the
patients most in need of a review, if the less acute patients
must often be prioritized in order to be reimbursed properly?
GP: general practitioner
First, external steering as represented by the guide-
lines (supplementary file) caused frustration and even
passiveness, as they challenged GPs’ capacity to cor-
rectly evaluate a patient’s medical complaints. Second,
GPs and nurses perceived that financial incentives
forced them to perform MRs when they were actually
not indicated from a medical point of view, which
even made them lose time for those patients who
were in need of their help.
The relationship between the five themes
The five themes related to each other as illustrated in
Figure 1. The complexity of PIMs and MRs as proposed
by the guidelines is represented by the bottom of the
balance. MRs are a possible measure to reduce PIMs.
However, GPs and nurses expressed that the factors
(=balance weights¼ themes) complicating the per-
formance of such MRs outweighed those facilitating
their performance (Figure 1).
Discussion
GPs’ and nurses’ experiences with MRs could be
grouped into five themes and 15 subthemes. There
was consensus among GPs and nurses regarding the
complexity of the clinical evaluation of elderly patients
and their drug treatment (theme 1) as well as the
effect of external steering and financial incentives on
GPs’ autonomy (theme 5). GPs and nurses disagreed
with several aspects of the guidelines’ definition of
MRs (theme 2). Due to organizational obstacles they
were at times forced to choose suboptimal solutions
when implementing the guideline on MRs (theme 3).
GPs’ and nurses’ experiences regarding different steps
during a MR varied (theme 4). Factors complicating
the performance of MRs as proposed by the guidelines
outweighed those facilitating their performance.
In many cases diaries are not created by the sub-
jects who are the focus of the research [16], as was
the case even in our study where pharmacists docu-
mented GPs’ and nurses’ experiences. Still, diaries may
be an important and valuable data source in qualita-
tive research as they help researchers to learn more
about the participants’ views [16]. A weakness with
diaries is that they, contrary to semi-structured inter-
views, do not allow to gain a deeper understanding.
Another weakness is that the dialogues during the
educational sessions were not recorded, which makes
it difficult to evaluate if the tutors reported selectively.
Still, this seems unlikely as the diaries were written
with the purpose to memorize what had been said
and expressed by the participants thus documenting
the pedagogical process and allowing a natural start-
ing point for the follow up session; reporting select-
ively would thus have impeded the usefulness of the
diaries for the tutors.
We performed a secondary analysis of qualitative
data, meaning that the data material served to answer
a research question that differs from the original pur-
pose of data collection [25]. Secondary analysis of
qualitative data has been described as a valuable
research method, if the researcher is aware of the
strengths and limitations of such analyses [25].
Therefore, the results were validated by three GPs and
two nurses who had not participated in the educa-
tional sessions. They recognized themselves in the
themes and subthemes. However, one GP experienced
that there were more positive experiences with MRs
among GPs and nurses in clinical practice than we
have captured in this study. This would imply that the
balance in Figure 1 may tilt over more to the right
than our data suggest, i.e. themes facilitating MRs are
more balanced. A possible explanation for this finding
may be that the tutors were pharmacists and spokes-
men for MRs as proposed by the guidelines (supple-
mentary file), which may have enhanced GPs’ and
nurses’ resistance to the message the tutors delivered.
Another explanation may be that GPs and nurses
partly commented on MRs as part of an implemented
control system even including financial incentives
rather than MRs as a medical procedure. Still, it is a
long tradition in Stockholm County that pharmacists
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from the regional drug and therapeutics committee
perform educational outreach visits in primary care
[19], and healthcare professionals respect the role of
educating pharmacists. This committee is well recog-
nised by GPs and nurses as a source of independent
drug information, and educational outreach visits per-
formed by the committee are an established way of
implementing knowledge in primary care. The Drug
committee may thus be considered as one of the
”addressers“ of the medical procedure on MRs. We
therefore think that the negative experiences GPs and
nurses described in our study rather refer to the med-
ical procedure than the implemented control system.
MRs as proposed by the guidelines (supplementary
file) are complicated to perform as they involve both
the collaboration between the patient and different
healthcare professionals as well as the screening for
multiple inappropriate drugs or drug combinations.
GPs and nurses experience that such procedure is diffi-
cult to implement in clinical practice (box 5). This
result is consistent with previous studies where clini-
cians have expressed a desire for simpler measures
that are more compatible with current clinical practice
[14]. Moreover, GPs and nurses expressed that the clin-
ical evaluation of the elderly patient was complex.
One aspect in particular was the inherent difficulty in
distinguishing symptoms due to side effects of drug
treatment versus those of chronic disease (box 1). The
challenge of recognizing side effects of drug treatment
has been described by GPs earlier [26]. In order to
facilitate symptom evaluation in older patients, the
guidelines on MRs (supplementary file) recommend
the use of standardized questionnaires screening for
common side effects of drug treatment [27]. However,
GPs and nurses in our study experienced that the use-
fulness of such a questionnaire varied as they for
example found it difficult to interpret the answers
(box 4).
GPs and nurses disagreed with several aspects of
the guidelines’ definition of MRs. The guidelines rec-
ommend MRs for all patients aged 75 and older with
more than five drugs (supplementary file), whereas
GPs and nurses in our study disagreed that age is a
valuable reason to perform a MR (box 2). In a study by
Sinnige et al. GPs expressed that they feel uncertain
about which patients are eligible for a review [28].
Sinniges as well as our findings illustrate that it is
important to define more thoroughly which patients
are in need of a MR.
In contrast to the guidelines (supplementary file)
GPs and nurses expressed that MRs are part of every
consultation (box 2), and they questioned the
Figure 1. Visualisation of the imbalance between factors (¼ balance weights¼ themes¼ T) counteracting and facilitating the per-
formance of medication reviews. The figure was created based on GPs and nurses expressed views. Of note, T2, T3 and T5 have
been placed on the balance in a random order as we consider them to have the same weight. Abbreviations: T1: Complexity in 3
P: patients, pharmacotherapy, and primary care; T2: What, when, who? Clash between GPsand nursesexperiences and the guide-
lines; T3: Real-world problems and less-than-ideal solutions; T4: Eureka? Experiences with different steps during a medication
review; T5: Threats to GPsautonomy.
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differentiation between basic and complex MRs (box
2). This raises the question to what extent the guide-
lines’ definition of MRs and GPs’ and nurses’ definition
actually overlap. In general, prescribers often describe
negative attitudes towards guidelines, as they may feel
the pressure to adopt them even if the guidelines do
not fit clinical practice [12]. However, there are import-
ant arguments to stimulate the performance of regular
MRs as a distinct measure apart from being “part of
every consultation” (box 2), and thus to consider mul-
timorbidity and polypharmacy as a distinct disease
entity. First, multimorbidity is more common in elderly
patients in primary care than single disease [29].
Second, GPs would be liberated from the uncertainty
they experience in relation to their responsibility of
the current drug list (box 2) [10] [30], as they would
have a clear mandate to treat multimorbid patients
instead of patients with a sum of several disease con-
ditions. Third, GPs might dare to deprescribe more
easily and accept that they ‘in a way preside over the
subspecialist’ (box 2). Recommendations on the care
of multimorbid elderly patients have recently been
released by the National Institute for Health and Care
Excellence as well as the The Royal college of GPs in
UK [31,32]. Important suggestions are amongst others
distinct MRs with a greater focus on the effectiveness
of drug treatment; and that not a single disease itself
but instead, the patient’s needs should be prioritized
when optimizing drug treatment. In this context, an
interesting attempt has been made by van Summeren
et al. [33] who proposes the use of an “outcome priori-
tization tool for MRs”. Major effects of such a tool
would be to involve patients in the decision-making
process, but even to help prescribers to overcome
their fear of being blamed for negative effects of
deprescribing [32].
MRs as proposed by the guidelines are difficult to
implement in primary care. GPs and nurses should par-
ticipate in the construction and release of such guide-
lines in order to increase their usability in clinical
practice. Furthermore, the multistep procedure should
be condensed to the most important steps. Several
former research findings may point towards how a MR
may be facilitated in order to be applicable in clinical
practice. First, during a MR it is necessary to focus on
the detection of the most frequently encountered
drug-related problems in elderly patients in primary
care. A lack of indication and effectiveness of drug
treatment as well as a too long duration of drug treat-
ment accounted for more than one third of drug-
related problems in elderly outpatients in Denmark
[34] and the US [35]. In an Israeli study, MRs in elderly
multimorbid patients consisted of checking the
indication of treatment in relation to the patients’ age,
comorbidity and possible adverse drug reactions [36].
As a consequence, in mean 4,4 drugs per patient
could be removed, the participants’ quality of life
increased, and dementia symptoms in three patients
diminished. To assure both the indication and effect-
iveness of drug treatment must therefore be consid-
ered as the two most important steps during a MR
minimizing a large proportion of all drug-related prob-
lems. Drug-drug interactions for instance are closely
associated to the number of drugs which implies that
they are reduced automatically when clinically
unnecessary drugs are removed [37]. Second, the large
majority of drug-related morbidity is caused by a lim-
ited number of PIMs such as anticoagulants, oral anti-
platelet agents, non-steroidal anti-inflammatory drugs,
hypoglycemic agents and central-nervous system act-
ing drugs [38]. A Scottish study focused on feedback
on prescribing of nine PIMs with the potential of ser-
ious side effects, namely gastrointestinal bleeding,
renal failure and heart failure [39]. As a result, drug-
related hospitalizations and PIM use decreased. This
illustrates that it may be sufficient to screen for a lim-
ited but clinically relevant number of PIMs. Finally, it
has been shown that certain drug-related problems
are more common in presence of certain patterns of
morbidity [40]. To give an example, patients with a
combination of diabetes and renal impairment had a
higher likelihood of drug-disease interactions than
patients with diabetes only. The identification of more
such morbidity patterns would enable clinicians to tar-
get MRs at patients at risk for drug-related problems.
Future research should analyse if condensed MRs
and feedback on prescribing can be implemented in
primary care, and if GPs and nurses experience that
these are applicable and helpful measures in clinical
practice. Furthermore, those affected by those meas-
ures should be enquired about their experiences.
Finally, the effects of those measures on health-related
patient outcomes should be evaluated.
Conclusion
The pharmacists’ diaries showed that GPs and nurses
should not be forced to perform MRs according to
guidelines which do not fit clinical practice in primary
care. Instead, GPs and nurses should take part in the
construction and release of guidelines on MRs, in order
to increase their acceptance amongst health care pro-
fessionals as well as their usability in clinical work.
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